Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Crossover Study to Evaluate Insulin/Pramlintide Versus Insulin Alone Delivery Strategy

NCT06422325 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT06422325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06422325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Crossover Study to Evaluate Insulin/Pramlintide Versus Insulin Alone Delivery Strategy
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Completed
Start date
July 12, 2024
Completion date
January 28, 2025
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes